A major challenge in the field of neurocomputing is to mimic the brain's behavior by implementing artificial synapses and neurons directly in hardware. Toward that purpose, many researchers are exploring the potential of new materials and new physical phenomena. Recently, a new concept of the Leaky Integrate and Fire (LIF) artificial neuron was proposed based on the electric Mott transition in the inorganic Mott insulator GaTa4Se8. In this work, we report on the LIF behavior in simple two-terminal devices in three chemically very different compounds, the oxide (V0.89Cr0.11)2O3, the sulfide GaMo4S8, and the molecular system [Au(iPr-thiazdt)2] (C12H14AuN2S8), but sharing a common feature, their Mott insulator ground state. In all these devices, the application of an electric field induces a volatile resistive switching and a remarkable LIF behavior under a train of pulses. It suggests that the Mott LIF neuron is a general concept that can be extended to the large class of Mott insulators.
The anticancer, antimicrobial and antiplasmodial activities of six gold(iii) bis(dithiolene) complexes were studied. Complexes 1–6 showed relevant anticancer properties against A2780/A2780cisR ovarian cancer cells (IC50 values of 0.08–2 μM), also being able to overcome cisplatin resistance in A2780cisR cells. Complex 1 also exhibited significant antimicrobial activity against Staphylococcus aureus (minimum inhibitory concentration (MIC) values of 12.1 ± 3.9 μg mL−1) and both Candida glabrata and Candida albicans (MICs of 9.7 ± 2.7 and 19.9 ± 2.4 μg mL−1, respectively). In addition, all complexes displayed antiplasmodial activity against the Plasmodium berghei parasite liver stages, even exhibiting better results than the ones obtained using primaquine, an anti-malarial drug. Mechanistic studies support the idea that thioredoxin reductase, but not DNA, is a possible target of these complexes. Complex 1 is stable under biological conditions, which would be important if this compound is ever to be considered as a drug. Overall, the results obtained evidenced the promising biological activity of complex 1, which might have potential as a novel anticancer, antimicrobial and antiplasmodial agent to be used as an alternative to current therapeutics.